1700027F06Rik Inhibitors comprise a diverse range of compounds that can interact with and modulate the activity of the protein encoded by the gene 1700027F06Rik. These inhibitors display varied chemical structures and properties, each designed to influence the activity of the 1700027F06Rik protein in specific ways. They can act through multiple mechanisms, such as direct binding to the protein, altering its structural conformation, affecting its enzymatic activity, or disrupting its interaction with other cellular molecules. The diversity in their mechanisms reflects the complexity of protein functions and cellular biochemical networks.
The development and study of these inhibitors necessitate extensive scientific efforts, integrating molecular biology, chemistry, and computational biology. Advanced computational methods are employed to model the protein structure and predict potential binding sites for inhibitors. The synthesis of these molecules uses sophisticated techniques in synthetic chemistry, aiming to create compounds ranging from small, targeted molecules to larger, more complex structures. Experimental validation, including biochemical assays and cellular studies, is critical to determine the actual impact of these inhibitors on the protein's function. This research not only contributes to the understanding of the specific protein but also enhances broader knowledge in cellular biochemistry and molecular biology.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Kinase inhibitor, can disrupt phosphorylation processes potentially involving 1700027F06Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor, can impact the PI3K/Akt signaling pathway, potentially affecting 1700027F06Rik. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, can influence cell growth and autophagy, potentially impacting 1700027F06Rik. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
HDAC inhibitor, can modify gene expression and chromatin structure, potentially affecting 1700027F06Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MAPK/ERK pathway inhibitor, can alter cell signaling processes involving 1700027F06Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor, can disrupt stress response and inflammation, potentially linked to 1700027F06Rik. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, can alter stress response and apoptosis, potentially involving 1700027F06Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor, can disrupt various signaling pathways potentially linked to 1700027F06Rik. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor, can influence protein degradation, potentially impacting 1700027F06Rik. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Calcium channel blocker, can alter calcium signaling, potentially affecting 1700027F06Rik. | ||||||